PharmaLegacy, a leading CRO since 2008, provides in vivo pharmacology services with over 1500 clinically predictive animal disease models, covering inflammation/autoimmune diseases, immuno-oncology/oncology, metabolic diseases, ophthalmology, cardiovascular diseases, CNS, bone, and hearing loss, etc. across species from rodents to NHPs. We specialize in integrating PK, PD, and ex-vivo endpoints into study designs and conducting ADME assays and non-GLP and GLP toxicology studies. Our Shanghai headquarter and San Diego site feature AAALAC accredited vivariums.

www.pharmalegacy.com